BioCentury | Sep 21, 2017
Tools & Techniques

On your marks

...therapy; inhibiting PHF8 could help treat anxiety and depression RNA acetyltransferase N-acetyltransferase 10 (NAT10) Other Progeria Inhibiting NAT10...
BioCentury | Jun 5, 2014
Distillery Therapeutics

Indication: Cancer

...Feinberg School of Medicine, Chicago, Ill. e-mail: d-vaughan@northwestern.edu Progeria N-acetyltransferase 10 (NAT10) In vitro studies suggest inhibiting NAT10...
...progeria. A chemical derivative of the compound called Remodelin was generated and shown to inhibit NAT10...
...anchorage compared with no treatment. Next steps include evaluating the potential of Remodelin or other NAT10...
BioCentury | Jun 5, 2014
Distillery Therapeutics

Indication: Other

...Summary Licensing status Publication and contact information Other Progeria N-acetyltransferase 10 (NAT10) In vitro studies suggest inhibiting NAT10...
...progeria. A chemical derivative of the compound called Remodelin was generated and shown to inhibit NAT10...
...anchorage compared with no treatment. Next steps include evaluating the potential of Remodelin or other NAT10...
BioCentury | Mar 18, 2010
Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer N(a)-acetyltransferase 10 (NAA10; ARD1A) In vitro and mouse studies suggest that increasing ARD1A expression could help treat cancer. In a mouse model of intestinal...
Items per page:
1 - 4 of 4